PAIA
CELG

Park Avenue Institutional Advisers’s Celgene Corp CELG Stock Holding History

Park Avenue Institutional Advisers’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,937
Closed -$487K – 502
2016
Q2 		$487K Sell
4,937
-13
-0.3% -$1.34K 0.42% 52
2016
Q1 		$495K Sell
4,950
-139
-3% -$14.3K 0.43% 52
2015
Q4 		$609K Sell
5,089
-170
-3% -$19.7K 0.52% 44
2015
Q3 		$569K Sell
5,259
-140
-3% -$17.4K 0.5% 46
2015
Q2 		$625K Buy
+5,399
New +$617K 0.5% 46

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Park Avenue Institutional Advisers's CELG Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of Celgene Corp (CELG) in Q3 2016, closing a stake of 4,937 shares — an estimated $487K sold.

Park Avenue Institutional Advisers first reported a position in CELG in Q2 2015 and held it in 5 quarters. The position peaked at $625K in Q2 2015. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining Celgene Corp position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 4,937 Celgene Corp shares in Q3 2016, an estimated $487K.
  • Park Avenue Institutional Advisers first reported a position in Celgene Corp in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's Celgene Corp position peaked at $625K in Q2 2015.
  • 1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.